Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sefina Arif

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
The Journal of Clinical Investigation|February 3, 2004
Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in healthSefina Arif, Timothy I Tree, Thomas P Astill, et al.
Frontiers in Immunology|July 15, 2021
Mapping T Cell Responses to Native and Neo-Islet Antigen Epitopes in at Risk and Type 1 Diabetes SubjectsSefina Arif, Irma Pujol-Autonell, Yogesh Kamra, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2008
Retargeting of human T cells to tumor-associated MUC1: the evolution of a chimeric antigen receptorScott Wilkie, Gianfranco Picco, Julie Foster, et al.
Diabetes|August 14, 2009
Validity and reproducibility of measurement of islet autoreactivity by T-cell assays in subjects with early type 1 diabetesKevan C Herold, Barbara Brooks-Worrell, Jerry Palmer, et al.
Diabetes|October 4, 2013
Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetesMenno van Lummel, Gaby Duinkerken, Peter A van Veelen, et al.
Diabetologia|April 6, 2020
GAD-alum immunotherapy in type 1 diabetes expands bifunctional Th1/Th2 autoreactive CD4 T cellsSefina Arif, Iria Gomez-Tourino, Yogesh Kamra, et al.
Diabetes|January 24, 2022
Immune and Metabolic Effects of Antigen-Specific Immunotherapy Using Multiple β-Cell Peptides in Type 1 DiabetesYuk-Fun Liu, Jake Powrie, Sefina Arif, et al.
Diabetes|June 11, 2011
Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated β-cell deathSefina Arif, Fabrice Moore, Katherine Marks, et al.
Diabetes|January 1, 2016
Discovery of a Selective Islet Peptidome Presented by the Highest-Risk HLA-DQ8trans MoleculeMenno van Lummel, Peter A van Veelen, Arnoud H de Ru, et al.
Frontiers in Immunology|August 8, 2025
Blood samples collected under anesthesia can be used as a source of non-diseased controls for immune-based assaysClara Domingo-Vila, Evangelia D Williams, Megan E Smithmyer, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
The Journal of Clinical Investigation|February 3, 2004
Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in healthSefina Arif, Timothy I Tree, Thomas P Astill, et al.
Frontiers in Immunology|July 15, 2021
Mapping T Cell Responses to Native and Neo-Islet Antigen Epitopes in at Risk and Type 1 Diabetes SubjectsSefina Arif, Irma Pujol-Autonell, Yogesh Kamra, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2008
Retargeting of human T cells to tumor-associated MUC1: the evolution of a chimeric antigen receptorScott Wilkie, Gianfranco Picco, Julie Foster, et al.
Diabetes|August 14, 2009
Validity and reproducibility of measurement of islet autoreactivity by T-cell assays in subjects with early type 1 diabetesKevan C Herold, Barbara Brooks-Worrell, Jerry Palmer, et al.
Diabetes|October 4, 2013
Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetesMenno van Lummel, Gaby Duinkerken, Peter A van Veelen, et al.
Diabetologia|April 6, 2020
GAD-alum immunotherapy in type 1 diabetes expands bifunctional Th1/Th2 autoreactive CD4 T cellsSefina Arif, Iria Gomez-Tourino, Yogesh Kamra, et al.
Diabetes|January 24, 2022
Immune and Metabolic Effects of Antigen-Specific Immunotherapy Using Multiple β-Cell Peptides in Type 1 DiabetesYuk-Fun Liu, Jake Powrie, Sefina Arif, et al.
Diabetes|June 11, 2011
Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated β-cell deathSefina Arif, Fabrice Moore, Katherine Marks, et al.
Diabetes|January 1, 2016
Discovery of a Selective Islet Peptidome Presented by the Highest-Risk HLA-DQ8trans MoleculeMenno van Lummel, Peter A van Veelen, Arnoud H de Ru, et al.
Frontiers in Immunology|August 8, 2025
Blood samples collected under anesthesia can be used as a source of non-diseased controls for immune-based assaysClara Domingo-Vila, Evangelia D Williams, Megan E Smithmyer, et al.
Pageof 3